CNP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.423800E-01
Normal-vs-Stage2
4.919600E-01
Normal-vs-Stage3
4.241800E-01
Normal-vs-Stage4
5.289400E-01
Stage1-vs-Stage2
9.060400E-01
Stage1-vs-Stage3
4.890800E-01
Stage1-vs-Stage4
8.119800E-01
Stage2-vs-Stage3
3.202200E-01
Stage2-vs-Stage4
8.497800E-01
Stage3-vs-Stage4
6.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.831200E-01
Normal-vs-AfricanAmerican
5.084200E-01
Normal-vs-Asian
4.244000E-01
Caucasian-vs-AfricanAmerican
8.118300E-03
Caucasian-vs-Asian
7.354800E-01
AfricanAmerican-vs-Asian
5.434000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.199000E-01
Normal-vs-Female
5.715000E-01
Male-vs-Female
7.589800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.390000E-01
Normal-vs-Age(41-60Yrs)
8.074200E-01
Normal-vs-Age(61-80Yrs)
4.834200E-01
Normal-vs-Age(81-100Yrs)
6.910300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.093600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.596780E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.016500E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.985590E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.482390E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.310300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.212800E-01
Normal-vs-Daily Drinker
2.758000E-01
Normal-vs-Weekly Drinker
7.933000E-01
Normal-vs-Occasional Drinker
8.266200E-01
Normal-vs-Social Drinker
9.242000E-01
Non Drinker-vs-Daily Drinker
9.530800E-01
Non Drinker-vs-Weekly Drinker
2.302800E-01
Non Drinker-vs-Occasional Drinker
9.399700E-02
Non Drinker-vs-Social Drinker
6.812500E-02
Daily Drinker-vs-Weekly Drinker
1.475790E-01
Daily Drinker-vs-Occasional Drinker
6.666100E-02
Daily Drinker-vs-Social Drinker
2.372300E-02
Weekly Drinker-vs-Occasional Drinker
8.759200E-01
Weekly Drinker-vs-Social Drinker
5.100200E-01
Occasional Drinker-vs-Social Drinker
5.517400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.322200E-01
Normal-vs-Grade 2
5.298000E-01
Normal-vs-Grade 3
5.221600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.950200E-01
Grade 1-vs-Grade 3
4.914200E-01
Grade 1-vs-Grade 4
1.322200E-01
Grade 2-vs-Grade 3
8.137800E-01
Grade 2-vs-Grade 4
5.298000E-01
Grade 3-vs-Grade 4
5.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.536800E-01
Normal-vs-NonDiabetic
6.874400E-01
Diabetic-vs-NonDiabetic
6.610000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.877200E-01
Normal-vs-NoPancreatitis
5.448800E-01
Pancreatitis-vs-NoPancreatitis
8.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.256600E-01
Normal-vs-N1
4.807800E-01
N0-vs-N1
6.352600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.391800E-01
Normal-vs-TP53-NonMutant
5.802000E-01
TP53-Mutant-vs-TP53-NonMutant
9.096800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
